What is she best known for?
The fields of study she is best known for:
Her main research concerns Mucin, MUC1, Antigen, Cancer research and Molecular biology.
Sandra J. Gendler has researched Mucin in several fields, including Epitope, Glycosylation, Glycoprotein and Mucin 2.
Sandra J. Gendler combines subjects such as Cell, Signal transduction, Function, Cell biology and Transmembrane protein with her study of MUC1.
Antigen is the subject of her research, which falls under Immunology.
Her Cancer research research is multidisciplinary, incorporating elements of Cancer, Breast cancer, Mammary tumor, ErbB and Mouse mammary tumor virus.
Her Molecular biology study frequently links to adjacent areas such as Complementary DNA.
Her most cited work include:
- Epithelial Mucin Genes (872 citations)
- A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. (523 citations)
- Structure and Function of the Cell Surface (Tethered) Mucins (501 citations)
What are the main themes of her work throughout her whole career to date?
Sandra J. Gendler spends much of her time researching MUC1, Immunology, Cancer research, Mucin and Molecular biology.
The concepts of her MUC1 study are interwoven with issues in Endocrinology, Genetically modified mouse, Transgene and Cell biology.
Her work deals with themes such as Cytotoxic T cell and Cancer, which intersect with Immunology.
The study incorporates disciplines such as Pancreatic cancer, Breast cancer, Mammary tumor, Carcinogenesis and Tumor progression in addition to Cancer research.
Her Mucin research incorporates themes from Glycosylation, Antibody, Cystic fibrosis and Transmembrane protein.
Her Molecular biology research focuses on Gene and how it connects with Nucleic acid.
She most often published in these fields:
- MUC1 (39.62%)
- Immunology (30.82%)
- Cancer research (27.67%)
What were the highlights of her more recent work (between 2010-2018)?
- MUC1 (39.62%)
- Immunology (30.82%)
- Cancer research (27.67%)
In recent papers she was focusing on the following fields of study:
Her scientific interests lie mostly in MUC1, Immunology, Cancer research, Immune system and Antigen.
Her MUC1 study is within the categories of Internal medicine and Mucin.
Her Immunology course of study focuses on Cytotoxic T cell and Immunogenicity.
Sandra J. Gendler has included themes like Pancreatic cancer, Catenin, Pathology, Metastasis and Tumor progression in her Cancer research study.
Her study explores the link between Immune system and topics such as Cancer that cross with problems in Family medicine.
Her Antigen research includes elements of Molecular biology, Glycosylation, Antibody and Tumor-Derived.
Between 2010 and 2018, her most popular works were:
- Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine (219 citations)
- Importance and regulation of the colonic mucus barrier in a mouse model of colitis (217 citations)
- MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition (187 citations)
In her most recent research, the most cited papers focused on:
Her primary scientific interests are in MUC1, Cancer research, Antigen, Immunology and Mucin.
Her Cancer research research includes themes of Sunitinib, Signal transduction, Metastasis and Pancreatic cancer.
Her Pancreatic cancer research is multidisciplinary, relying on both Tumor progression and Catenin.
Her Antigen study combines topics in areas such as Cancer vaccine, Antibody, Antibody-dependent cell-mediated cytotoxicity and Mammary tumor virus.
Her Antibody research is multidisciplinary, incorporating elements of Molecular biology and Glycosylation.
Her study in Mucin is interdisciplinary in nature, drawing from both Lipopolysaccharide, Microbiology, Ulcerative colitis, Peptidoglycan and Mucin 2.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
